Towards a comprehensive Plasmodium falciparum merozoite cell surface and secreted recombinant protein library

BackgroundPlasmodium falciparum is the aetiological agent for malaria, a deadly infectious disease for which no vaccine has yet been licensed. The proteins displayed on the merozoite cell surface have long been considered attractive vaccine targets because of their direct exposure to host antibodies; however, progress in understanding the functional role of these targets has been hindered by technical challenges associated with expressing these proteins in a functionally active recombinant form. To address this, a method that enables the systematic expression of functional extracellular Plasmodium proteins was previously developed, and used to create a library of 42 merozoite proteins.MethodsTo compile a more comprehensive library of recombinant proteins representing the repertoire of P. falciparum merozoite extracellular proteins for systematic vaccine and functional studies, genome-wide expression profiling was used to identify additional candidates. Candidate proteins were recombinantly produced and their integrity and expression levels were tested by Western blotting and ELISA.ResultsTwenty-five additional genes that were upregulated during late schizogony, and predicted to encode secreted and cell surface proteins, were identified and expressed as soluble recombinant proteins. A band consistent with the entire ectodomain was observed by immunoblotting for the majority of the proteins and their expression levels were quantified. By using sera from malaria-exposed immune adults, the immunoreactivity of 20 recombinant proteins was assessed, and most of the merozoite ligands were found to carry heat-labile epitopes. To facilitate systematic comparative studies across the entire library, multiple Plasmodium proteins were simultaneously purified using a custom-made platform.ConclusionsA library of recombinant P. falciparum secreted and cell surface proteins was expanded by 20 additional proteins, which were shown to express at usable levels and contain conformational epitopes. This resource of extracellular P. falciparum merozoite proteins, which now contains 62 full-length ectodomains, will be a valuable tool in elucidating the function of these proteins during the blood stages of infection, and facilitate the comparative assessment of blood stage vaccine candidates.

[1]  Julian C. Rayner,et al.  A Library of Functional Recombinant Cell-surface and Secreted P. falciparum Merozoite Proteins* , 2013, Molecular & Cellular Proteomics.

[2]  Manuel Llinás,et al.  Comparative whole genome transcriptome analysis of three Plasmodium falciparum strains , 2006, Nucleic acids research.

[3]  M. Gallagher-Jones,et al.  A benchmarked protein microarray-based platform for the identification of novel low-affinity extracellular protein interactions , 2012, Analytical biochemistry.

[4]  A. Holder,et al.  Merozoite surface proteins of the malaria parasite: the MSP1 complex and the MSP7 family. , 2010, International journal for parasitology.

[5]  Dominic P. Kwiatkowski,et al.  BASIGIN is a receptor essential for erythrocyte invasion by Plasmodium falciparum , 2011, Nature.

[6]  M. Grainger,et al.  Deletion of the Plasmodium falciparum Merozoite Surface Protein 7 Gene Impairs Parasite Invasion of Erythrocytes , 2008, Eukaryotic Cell.

[7]  Alex Bateman,et al.  Large-scale screening for novel low-affinity extracellular protein interactions. , 2008, Genome research.

[8]  I. McGregor,et al.  Gamma-Globulin and Acquired Immunity to Human Malaria , 1961, Nature.

[9]  Danny W. Wilson,et al.  Biochemical and Functional Analysis of Two Plasmodium falciparum Blood-Stage 6-Cys Proteins: P12 and P41 , 2012, PloS one.

[10]  J. Barnwell,et al.  A Conserved Multi-Gene Family Induces Cross-Reactive Antibodies Effective in Defense against Plasmodium falciparum , 2009, PloS one.

[11]  Y. Durocher,et al.  High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. , 2002, Nucleic acids research.

[12]  J. Rayner,et al.  A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants , 2013, Vaccine.

[13]  Jonathan E. Allen,et al.  Genome sequence of the human malaria parasite Plasmodium falciparum , 2002, Nature.

[14]  Nancy Fullman,et al.  Global malaria mortality between 1980 and 2010: a systematic analysis , 2012, The Lancet.

[15]  Virander S. Chauhan,et al.  Expression of Plasmodium falciparum C-terminal region of merozoite surface protein (PfMSP119), a potential malaria vaccine candidate, in tobacco , 2002 .

[16]  Alexey Bochkarev,et al.  Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms. , 2007, Molecular and biochemical parasitology.

[17]  S. Ralph,et al.  An EGF-like Protein Forms a Complex with PfRh5 and Is Required for Invasion of Human Erythrocytes by Plasmodium falciparum , 2011, PLoS pathogens.

[18]  Kevin Marsh,et al.  Erratum: Corrigendum: The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody , 2013 .

[19]  S. Lindquist,et al.  Plasmodium falciparum heat shock protein 110 stabilizes the asparagine repeat-rich parasite proteome during malarial fevers , 2012, Nature Communications.

[20]  Ogobara K. Doumbo,et al.  The pathogenic basis of malaria , 2002, Nature.

[21]  Wim G J Hol,et al.  Heterologous expression of proteins from Plasmodium falciparum: results from 1000 genes. , 2006, Molecular and biochemical parasitology.

[22]  Cécile Crosnier,et al.  A rapid and scalable method for selecting recombinant mouse monoclonal antibodies , 2010, BMC Biology.

[23]  A. Craig,et al.  European Vaccine Initiative: lessons from developing malaria vaccines , 2011, Expert review of vaccines.

[24]  Gavin J. Wright.  Signal initiation in biological systems: the properties and detection of transient extracellular protein interactions† †This article is part of a Molecular BioSystems themed issue on Computational and Systems Biology. , 2009, Molecular bioSystems.

[25]  H. Stunnenberg,et al.  Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice , 2008, Proceedings of the National Academy of Sciences.

[26]  W. Whitehouse,et al.  Invasion of erythrocytes by malaria merozoites. , 1975, Science.

[27]  Leemor Joshua-Tor,et al.  Structural Basis for the EBA-175 Erythrocyte Invasion Pathway of the Malaria Parasite Plasmodium falciparum , 2005, Cell.

[28]  A. Cowman,et al.  Invasion of Red Blood Cells by Malaria Parasites , 2006, Cell.

[29]  J. Derisi,et al.  The Transcriptome of the Intraerythrocytic Developmental Cycle of Plasmodium falciparum , 2003, PLoS biology.

[30]  G. Wunderlich,et al.  Plasmodium in the postgenomic era: new insights into the molecular cell biology of malaria parasites. , 2008, International review of cell and molecular biology.

[31]  B. Mordmüller,et al.  Characterisation of a tryptophan-rich Plasmodium falciparum antigen associated with merozoites. , 2004, Molecular and biochemical parasitology.

[32]  R. Schwarz,et al.  Apparent lack of N-glycosylation in the asexual intraerythrocytic stage of Plasmodium falciparum. , 1992, European journal of biochemistry.

[33]  S. Herrera,et al.  Expression and one-step purification of Plasmodium proteins in dictyostelium. , 2000, Molecular and biochemical parasitology.

[34]  Deepak Gaur,et al.  Erythrocyte binding protein PfRH5 polymorphisms determine species-specific pathways of Plasmodium falciparum invasion. , 2008, Cell host & microbe.

[35]  M. Wahlgren,et al.  Molecular Aspects of Severe Malaria , 1996, Clinical Microbiology Reviews.

[36]  G. Butcher,et al.  Action of Malarial Antibody in vitro , 1969, Nature.

[37]  J. Rayner,et al.  Identifying novel Plasmodium falciparum erythrocyte invasion receptors using systematic extracellular protein interaction screens , 2013, Cellular microbiology.

[38]  L. Miller,et al.  Overproduction of Pichia pastoris or Plasmodium falciparum protein disulfide isomerase affects expression, folding and O-linked glycosylation of a malaria vaccine candidate expressed in P. pastoris. , 2006, Journal of biotechnology.

[39]  J. Sattabongkot,et al.  Wheat Germ Cell-Free System-Based Production of Malaria Proteins for Discovery of Novel Vaccine Candidates , 2008, Infection and Immunity.

[40]  S. Brunak,et al.  SignalP 4.0: discriminating signal peptides from transmembrane regions , 2011, Nature Methods.

[41]  A. de Marco,et al.  Microbial Cell Factories Strategies for Successful Recombinant Expression of Disulfide Bond-dependent Proteins in Escherichia Coli , 2022 .

[42]  P. Bork,et al.  Prediction of potential GPI-modification sites in proprotein sequences. , 1999, Journal of molecular biology.

[43]  T. Taylor,et al.  Intravenous immunoglobulin in the treatment of paediatric cerebral malaria , 1992, Clinical and experimental immunology.

[44]  H. Stunnenberg,et al.  Characterization of a Conserved Rhoptry-Associated Leucine Zipper-Like Protein in the Malaria Parasite Plasmodium falciparum , 2008, Infection and Immunity.

[45]  Melina Fan,et al.  Addgene provides an open forum for plasmid sharing , 2012, Nature Biotechnology.

[46]  D. Garboczi,et al.  Dissection of Merozoite Surface Protein 3, a Representative of a Family of Plasmodium falciparum Surface Proteins, Reveals an Oligomeric and Highly Elongated Molecule* , 2005, Journal of Biological Chemistry.

[47]  J. Adams,et al.  Conserved residues in the Plasmodium vivax Duffy-binding protein ligand domain are critical for erythrocyte receptor recognition. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[48]  A. Cowman,et al.  Erythrocyte and reticulocyte binding-like proteins of Plasmodium falciparum. , 2012, Trends in parasitology.

[49]  Steven Johnson,et al.  Semaphorin-7A Is an Erythrocyte Receptor for P. falciparum Merozoite-Specific TRAP Homolog, MTRAP , 2012, PLoS pathogens.

[50]  Eileen Kraemer,et al.  PlasmoDB: a functional genomic database for malaria parasites , 2008, Nucleic Acids Res..

[51]  D. Kaslow,et al.  Structural conformers produced during malaria vaccine production in yeast , 2001, Yeast.

[52]  Gavin J. Wright,et al.  Avidity-based Extracellular Interaction Screening (AVEXIS) for the Scalable Detection of Low-affinity Extracellular Receptor-Ligand Interactions , 2012, Journal of visualized experiments : JoVE.

[53]  G. Blatch,et al.  Heterologous expression of plasmodial proteins for structural studies and functional annotation , 2008, Malaria Journal.

[54]  Zbynek Bozdech,et al.  Transcriptional profiling of growth perturbations of the human malaria parasite Plasmodium falciparum , 2010, Nature Biotechnology.

[55]  E. Birney,et al.  Pfam: the protein families database , 2013, Nucleic Acids Res..

[56]  S. Ralph,et al.  Reticulocyte-binding protein homologue 5 - an essential adhesin involved in invasion of human erythrocytes by Plasmodium falciparum. , 2009, International journal for parasitology.

[57]  T. Speed,et al.  A Subset of Plasmodium falciparum SERA Genes Are Expressed and Appear to Play an Important Role in the Erythrocytic Cycle* , 2002, The Journal of Biological Chemistry.

[58]  G. Vasta,et al.  Production of recombinant proteins from protozoan parasites. , 2010, Trends in parasitology.

[59]  S. Mayfield,et al.  Algae-Produced Pfs25 Elicits Antibodies That Inhibit Malaria Transmission , 2012, PloS one.

[60]  Steven Johnson,et al.  Biochemical Analysis of the Plasmodium falciparum Erythrocyte-binding Antigen-175 (EBA175)-Glycophorin-A Interaction , 2013, The Journal of Biological Chemistry.

[61]  S. Howell,et al.  Systematic Genetic Analysis of the Plasmodium falciparum MSP7-Like Family Reveals Differences in Protein Expression, Location, and Importance in Asexual Growth of the Blood-Stage Parasite , 2010, Eukaryotic Cell.

[62]  Erik L. L. Sonnhammer,et al.  A Hidden Markov Model for Predicting Transmembrane Helices in Protein Sequences , 1998, ISMB.

[63]  K. Marsh,et al.  Correction: Corrigendum: The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody , 2011, Nature Communications.